Company Profiles

driven by the PitchBook Platform

Tocagen

Description

Developer of cancer-selective gene therapy products. The company's novel gene therapy platform utilizes retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. It is designed to fight cancer through a combination of mechanisms of action without the autoimmune toxicities.

2007

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$2.74M

Latest Deal Amount

$113M

Total Amount Raised

Description

Developer of cancer-selective gene therapy products. The company's novel gene therapy platform utilizes retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. It is designed to fight cancer through a combination of mechanisms of action without the autoimmune toxicities.

Website:

www.tocagen.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Other Pharmaceuticals and Biotechnology

Primary Office

3030 Bunker Hill Street Suite 230 San Diego, CA 92109United States +1 (858) 412-8400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tocagen's full profile, request a free trial.

Tocagen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tocagen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tocagen Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Accelerate Brain Cancer CureOther000 0000000 0000
BiobritVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
National Brain Tumor SocietyCorporation000 0000000 0000
The American Brain Tumor AssociationOther000 0000000 0000
Accelerate Brain Cancer Cure Other
Biobrit Venture Capital
Individual Investor Angel (individual)
National Brain Tumor Society Corporation
The American Brain Tumor Association Other

Tocagen Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Martin DuvallChief Executive Officer & Board Member
Harry Gruber MDCo-Founder, Board Member & President, Research & Development
Thomas DarcyCo-Founder, Chief Financial Officer, Board Member & Executive Vice President
Ching-I ChenDirector, Process Development and Manufacturing
Douglas Jolly Ph.DExecutive Vice President, Co-Founder, Research & Pharmaceutical Development
Martin Duvall Chief Executive Officer & Board Member
Harry Gruber MD Co-Founder, Board Member & President, Research & Development
Thomas Darcy Co-Founder, Chief Financial Officer, Board Member & Executive Vice President
Ching-I Chen Director, Process Development and Manufacturing
Douglas Jolly Ph.D Executive Vice President, Co-Founder, Research & Pharmaceutical Development

Tocagen Board Members (9)

NameRepresentingRoleSinceContact
Info
David Parkinson MDSelfBoard Member000 0000
Dennis Berman JDTocagenCo-Founder, Board Member and Executive Vice President, Corporate Development000 0000
Faheem HasnainTocagenBoard Member000 0000
Franklin BergerSelfBoard Member000 0000
Harry Gruber MDTocagenCo-Founder, Board Member & President, Research & Development000 0000
David Parkinson MD Board Member Self
Dennis Berman JD Co-Founder, Board Member and Executive Vice President, Corporate Development Tocagen
Faheem Hasnain Board Member Tocagen
Franklin Berger Board Member Self
Harry Gruber MD Co-Founder, Board Member & President, Research & Development Tocagen
Request full access to PitchBook